Sfoglia per Corso Network oncology and precision medicine
Mostrati risultati da 1 a 7 di 7
Comprehensive profile in head and neck cancer patients treated with immunotherapy
2024
Immune receptor CD137 as a biomarker in solid tumors and potential immunotherapeutic target in glioblastoma
2024
MIRROR: a miRNA regulation-level network-based algorithm to study sexual dimorphism in cancer
2025
Network analysis to dissect glioblastoma immunosuppression complexity: identification of C-type lectins as potential therapeutic candidates and biomarkers
2025
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a network analysis
2024
Phase I study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric and young adult patients affected by relapsed/refractory central nervous system tumors: preliminary data
2025
Probing neutrophils heterogeneity in Glioblastoma: how the metabolism shapes the function of immunosuppressive CD71+Neutrophils
2023
Mostrati risultati da 1 a 7 di 7
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile